Interactions of mesenchymal stromal/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis

S Dehnavi, M Sadeghi, JT Afshari, M Mohammadi - Cellular Immunology, 2023 - Elsevier
Rheumatoid arthritis (RA) is considered to be a degenerative and progressive autoimmune
disorder. Although several medicinal regimens are used to treat RA, potential adverse …

[HTML][HTML] Essential oils and bioactive components against arthritis: A novel perspective on their therapeutic potential

M Marrelli, V Amodeo, MR Perri, F Conforti, G Statti - Plants, 2020 - mdpi.com
Essential oils (EOs) are known to possess a number of beneficial properties. Their
antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and cancer-preventing activities …

Examining the Relationship Between Rheumatoid Arthritis, Multimorbidity, and Adverse Health‐Related Outcomes: A Systematic Review

J Canning, S Siebert, BD Jani… - Arthritis Care & …, 2022 - Wiley Online Library
Objective Multimorbidity (the coexistence of two or more long‐term conditions) is highly
prevalent in people who have rheumatoid arthritis (RA). The present work systematically …

What is blockchain technology and its significance in the current healthcare system? A brief insight

SS Ahmad, S Khan, MA Kamal - Current pharmaceutical design, 2019 - ingentaconnect.com
Background: The promising eventual fate of blockchain in healthcare has a lot more
extensive prospect. Blockchain is a novel structure that gives another design to storage and …

Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system

MA Pabón-Porras, S Molina-Ríos… - SAGE Open …, 2019 - journals.sagepub.com
Rheumatoid arthritis and systemic lupus erythematosus are two highly prevalent
autoimmune diseases that generate disability and low quality of life. The innate immune …

One year in review 2019: novelties in the treatment of rheumatoid arthritis

E Silvagni, M Di Battista, A Bonifacio… - Clinical and …, 2019 - boa.unimib.it
The current treatment approach in rheumatoid arthritis (RA) follows a stepwise management,
starting from early introduction of conventional synthetic (cs) disease-modifying anti …

NLRP12 reduces proliferation and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by regulating the NF-κB and MAPK pathways

X Zhang, H Nan, J Guo, J Liu - European Cytokine Network, 2021 - Springer
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by
abnormal synovial hyperplasia and the release of inflammatory cytokines. NLRP12 is a …

[HTML][HTML] Metformin, an AMPK activator, inhibits activation of FLSs but promotes HAPLN1 secretion

Y Chen, F Qiu, B Yu, Y Chen, F Zuo, XY Zhu… - … Therapy Methods & …, 2020 - cell.com
AMP-activated protein kinase (AMPK) is essential for maintaining energy balance and has a
crucial role in various inflammatory pathways. In this study, AMPK levels positively …

[HTML][HTML] Vitamin D and VDR gene polymorphisms' association with rheumatoid arthritis in Lithuanian Population

E Punceviciene, J Gaizevska, R Sabaliauskaite… - Medicina, 2021 - mdpi.com
Background and Objectives: Rheumatoid arthritis (RA) is a chronic, inflammatory,
autoimmune, multi-factorial disease, in which environmental and genetic factors play a …

Spermidine inhibits joints inflammation and macrophage activation in mice with collagen-induced arthritis

H Yuan, SX Wu, YF Zhou, F Peng - Journal of Inflammation …, 2021 - Taylor & Francis
Purpose Spermidine (SPD) is a naturally occurring polyamine. In this study, we examined
the role and possible mechanism of SPD in collagen-induced arthritis (CIA) mice. Materials …